nach oben

Erschienen in:

28.06.2018 | Original Article

Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations

verfasst von: Chloe Grimmett, Charlotte Brooks, Alejandra Recio-Saucedo, Anne Armstrong, Ramsey I Cutress, D Gareth Evans, Ellen Copson, Lesley Turner, Bettina Meiser, Claire E. Wakefield, Diana Eccles, Claire Foster

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To develop a decision support tool for young women with breast cancer considering genetic testing for BRCA1/2 mutations soon after cancer diagnosis.

Methods

A four-stage iterative development process was employed; stage 1, literature review exploring the availability and efficacy of empirically tested decision support tools; stage 2, in-depth interviews with 29 young women (< 50 years) recently diagnosed with breast cancer, exploring information requirements and experiences of genetic testing decision making; stage 3, three focus groups (N = 21) exploring preferences for information presentation and prioritisation of content; stage 4, think-aloud interviews to refine the prototype (N = 16).

Results

Participants wanted information regarding the pros and cons of testing, the testing process and implications for their family, presented in a way that allowed them to choose the level of detail they required. They preferred the term ‘altered gene’, valued a medical word definition function and warnings before accessing sensitive information.

Conclusion

Participants valued the decision support tool, the accessibility of the information and its clinical endorsement. The decision support tool has considerable clinical utility as an adjunct to genetic counselling or for use in busy oncology clinics where formal genetic counselling may be unavailable.

Trainer AH, Lewis CR, Tucker K, Meiser B, Friedlander M, Ward RL (2010) The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol 7:708–717. https://doi.org/10.1038/nrclinonc.2010.175 CrossRefPubMed

Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB, Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, Fountzilas G, Pelttari LM, Tapper WJ, Durcan L, Cross SS, Pilarski R, Shapiro CL, Klemp J, Yao S, Garber J, Cox A, Brauch H, Ambrosone C, Nevanlinna H, Yannoukakos D, Slager SL, Vachon CM, Eccles DM, Fasching PA (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304–311. https://doi.org/10.1200/JCO.2014.57.1414 CrossRefPubMed

Scott CL, Swisher EM, Kaufmann SH (2015) Poly (ADP-ribose) polymerase inhibitors: recent advances and future development. J Clin Oncol 33:1397–1406. https://doi.org/10.1200/jco.2014.58.8848 CrossRefPubMedPubMedCentral

Tutt A, Ellis P, Kilburn L et al (2014) TNT: a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA 1/2 breast cancer. San Antonio Breast Cancer Symposium 2014; 9–13 December 2014; San Antonio, Texas, USA

Recio-Saucedo A, Gerty S, Foster C, Eccles D, Cutress RI (2016) Information requirements of young women with breast cancer treated with mastectomy or breast conserving surgery: a systematic review. Breast 25:1–13. https://doi.org/10.1016/j.breast.2015.11.001 CrossRefPubMed

Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C, Mitchell G (2008) Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 10:216. https://doi.org/10.1186/bcr2194 CrossRefPubMedPubMedCentral

O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR (2007) Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Mak 27:554–574. https://doi.org/10.1177/0272989X07307319 CrossRef

The Cochrane Collaboration (2017). Decision aids to help people who are facing health treatment or screening decisions (http://www.cochrane.org/CD001431/COMMUN_decision-aids-help-people-who-are-facing-health-treatment-or-screening-decisions)

Wakefield CE, Meiser B, Homewood J, Taylor A, Gleeson M, Williams R, the AGenDA Collaborative Group, Tucker K (2008) A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psychooncology 17:844–854. https://doi.org/10.1002/pon.1353 CrossRefPubMed

10.

Wakefield CE, Meiser B, Homewood J, Peate M, Kirk J, Warner B, Lobb E, Gaff C, Tucker K (2007) Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet Couns 16:325–339. https://doi.org/10.1007/s10897-006-9068-x CrossRefPubMed

11.

Wakefield CE, Meiser B, Homewood J, Peate M, Taylor A, Lobb E, Kirk J, Young MA, Williams R, Dudding T, Tucker K, the AGenDA Collaborative Group (2008) A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat 107:289–301. https://doi.org/10.1007/s10549-007-9539-2 CrossRefPubMed

12.

Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655. https://doi.org/10.1136/bmj.a1655 CrossRefPubMedPubMedCentral

13.

Grimmett C, Pickett K, Shepherd J et al (2017) Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer doi: https://doi.org/10.1016/j.pec.2017.11.016

14.

Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, Durand MA, Drake E, Joseph-Williams N, Khangura S, Saarimaki A, Sivell S, Stiel M, Bernstein SJ, Col N, Coulter A, Eden K, Härter M, Rovner MH, Moumjid N, Stacey D, Thomson R, Whelan T, van der Weijden T, Edwards A (2009) Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One 4:e4705. https://doi.org/10.1371/journal.pone.0004705 CrossRefPubMedPubMedCentral

15.

Reyna VF (2008) A theory of medical decision making and health: fuzzy trace theory. Med Decis Mak 28:850–865. https://doi.org/10.1177/0272989X08327066 CrossRef

16.

Ottawa Decision Support Framework https://decisionaid.ohri.ca/odsf.html

17.

Coulter A, Stilwell D, al KJ (2013) A systematic development process for patient decision aids. BMC Med Inform Decis 13:S2. https://doi.org/10.1186/1472-6947-13-s2-s2 CrossRef

18.

Gale NK, Heath G, Cameron E (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13:117. https://doi.org/10.1186/1471-2288-13-117 CrossRefPubMedPubMedCentral

19.

Yardley L, Morrison LG, Andreou P, Joseph J, Little P (2010) Understanding reactions to an internet-delivered health-care intervention: accommodating user preferences for information provision. BMC Med Inform Decis 10:52. https://doi.org/10.1186/1472-6947-10-52 CrossRef

20.

Kuhn J (2009) Decrypting the MoSCoW analysis (DITY weekly newsletter). itSM solutions http://www.itsmsolutions.com/newsletters/DITYvol5iss44.pdf

21.

Permuth-Wey J, Vadaparampil S, Rumphs A, Kinney AY, Pal T (2010) Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for Black women. Am J Med Genet A 152A:836–845. https://doi.org/10.1002/ajmg.a.33187 CrossRefPubMed

22.

Meiser B, Gleeson M, Watts K, Peate M, Zilliacus E, Barlow-Stewart K, Saunders C, Mitchell G, Kirk J (2012) Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing. Oncol Nurs Forum 39:E101–E111. https://doi.org/10.1188/12.ONF.E101-E111 CrossRefPubMed

23.

Thompson HS, Wahl E, Fatone A, Brown K, Kwate NOA, Valdimarsdottir H (2004) Enhancing the readability of materials describing genetic risk for breast cancer. Cancer Control 11:245–253. https://doi.org/10.1177/107327480401100406 CrossRefPubMed

24.

Venne VL, Hamann HA (2007) Successful use of peer educators for sharing genetic information. J Genet Couns 16:515–525. https://doi.org/10.1007/s10897-007-9087-2 CrossRefPubMed

25.

Vadaparampil ST, Malo TL, Nam KM, Nelson A, de la Cruz CZ, Quinn GP (2014) From observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivors. J Cancer Educ 29:709–719. https://doi.org/10.1007/s13187-014-0643-9 CrossRefPubMedPubMedCentral

26.

Sie AS, van Zelst-Stams WA, Spruijt L et al (2014) More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling. Familial Cancer 13:143–151. doi:https://doi.org/10.1007/s10689-013-9686-z

27.

Rapport F, Iredale R, Jones W, Sivell S, Edwards A, Gray J, Elwyn G (2006) Decision aids for familial breast cancer: exploring women’s views using focus groups. Health Expect 9:232–244. https://doi.org/10.1111/j.1369-7625.2006.00392.x CrossRefPubMedPubMedCentral

28.

The Royal Marsden NHS Foundation Trust UK (2013 – revised 2016) A beginner’s guide to BRCA\1 and BRCA\2 https://www.royalmarsden.nhs.uk/sites/default/files/files_trust/beginners-guide-to-brca1-and-brca2.PDF

29.

University Hospital Southampton NHS Foundation Trust UK (2016) BRCA genes and inherited breast and ovarian cancer, information for patients http://www.uhs.nhs.uk/Media/Controlleddocuments/Patientinformation/Genetics/BRCA-Genes-Inherited-Breast-and-ovarian-Cancer.pdf

30.

Understanding genetic tests for breast and ovarian cancer that runs in the family. Information and decision aid (2014) http://www.genetics.edu.au/publications-and-resources/booklets-and-pamphlets/understanding-genetic-tests-for-breast-and-ovarian-cancer-that-runs-in-the-family-information-and-decision-aid

31.

McCaffery K, Holmes-Rovner M, Smith S et al (2013) Addressing health literacy in patient decision aids. BMC Med Inform Decis 13:S10. https://doi.org/10.1186/1472-6947-13-S2-S10 CrossRef

32.

McLaughlin GH (1969) SMOG grading: a new readability formula. J Read 12:639–646

33.

Culver J, Macdonald D, Thornton A et al (2011) Development and evaluation of a decision aid for BRCA carriers with breast cancer. J Genet Couns 20:294–297. https://doi.org/10.1007/s10897-011-9350-4 CrossRefPubMedPubMedCentral

34.

Kurian AW, Li Y, Hamilton AS, Ward KC, Hawley ST, Morrow M, McLeod MC, Jagsi R, Katz SJ (2017) Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol 35:2232–2239. https://doi.org/10.1200/JCO.2016.71.6480 CrossRefPubMedPubMedCentral

Titel: Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations
verfasst von: Chloe Grimmett
Charlotte Brooks
Alejandra Recio-Saucedo
Anne Armstrong
Ramsey I Cutress
D Gareth Evans
Ellen Copson
Lesley Turner
Bettina Meiser
Claire E. Wakefield
Diana Eccles
Claire Foster
Publikationsdatum: 28.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4307-x

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Ambivalence over emotional expression and physical functioning and limitations: mediating and moderating effects of PTSD symptoms and acculturation among Chinese breast cancer survivors

Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review

Short and long-term impairments of cardiopulmonary fitness level in previous childhood cancer cases: a systematic review

The impact of an expressive writing intervention on quality of life among Chinese breast cancer patients undergoing chemotherapy

The effect of training interventions on physical performance, quality of life, and fatigue in patients receiving breast cancer treatment: a systematic review

Using photography to explore psychological distress in patients with pancreatic cancer and their caregivers: a qualitative study

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie